A Case of Short Stature and Severe Osteoporosis in a Young Man with Oculocutaneous Albinism: Syndrome or Coincidence?

被引:0
作者
Oyibo, Samson O. [1 ]
机构
[1] Peterborough City Hosp, Internal Med, Peterborough, England
关键词
idiopathic short stature; osteoporosis; oculocutaneous hypopigmentation; albinism; growth hormone therapy; insulin-like growth factor 1; syndrome or coincidence; case report; low-trauma fractures; syndromic albinism; HYPOPIGMENTATION SYNDROME; DENSITY; SKIN;
D O I
10.7759/cureus.7817
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oculocutaneous albinism (OCA) is a rare autosomal recessive congenital condition characterized by reduced or absent production of the pigment melanin by melanocytes. The affected individuals have increased susceptibility to sunburn and skin cancers. Osteoporosis is a disease entity characterized by the progressive loss of bone mineral density and the deterioration of bone micro-architecture, leading to an increased risk of developing low-trauma fractures. There are many causes of osteoporosis, ranging from primary to secondary causes. Short stature is defined as height less than two standard deviations below the age-specific and gender-specific mean (less than the 2.5th percentile). There have been rare case reports of individuals with OCA having associated osteoporosis or low bone mineral density and short stature. These cases have also been associated with severe skeletal, neurological, and psychomotor disabilities. We present a case of a young man with OCA and short stature who sustained a low-trauma intertrochanteric fracture to his femur bone and was subsequently diagnosed to have clinically significant osteoporosis. This case report while attempting to review the literature also emphasizes the importance of further research into the prevalence of these clinical features accompanying certain types of OCA and whether they are part of a single syndrome or just coincidental findings.
引用
收藏
页数:11
相关论文
共 20 条
[1]  
[Anonymous], 2020, PORT RAR DIS ORPH DR
[2]  
[Anonymous], ENDOCR PRACT
[3]   A HEREDITARY SYNDROME ASSOCIATION OF OCULOCUTANEOUS ALBINISM, DYSMORPHIC FEATURES AND SHORT STATURE [J].
BITOUN, P ;
MORELCHARRON, J .
OPHTHALMIC PAEDIATRICS AND GENETICS, 1990, 11 (03) :209-213
[4]   Pituitary Disorders and Osteoporosis [J].
Bolanowski, Marek ;
Halupczok, Jowita ;
Jawiarczyk-Przybylowska, Aleksandra J .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
[5]   Investigation and management of short stature [J].
Cheetham, Tim ;
Davies, Justin H. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (08) :767-771
[6]  
CLEMENS TL, 1982, LANCET, V1, P74
[7]   Clinical Dilemmas in Evaluating the Short Child [J].
Garganta, Melissa D. ;
Bremer, Andrew A. .
PEDIATRIC ANNALS, 2014, 43 (08) :321-327
[8]   Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis [J].
Gillberg, P ;
Mallmin, H ;
Petrén-Mallmin, M ;
Ljunghall, S ;
Nilsson, AG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11) :4900-4906
[9]   Oculocutaneous albinism [J].
Gronskov, Karen ;
Ek, Jakob ;
Brondum-Nielsen, Karen .
ORPHANET JOURNAL OF RARE DISEASES, 2007, 2 (1)
[10]   Oculocutaneous albinism and reduced bone density in two sibs:: a new autosomal recessive syndrome? [J].
Gül, D ;
Odabas, E ;
Kutlu, M .
CLINICAL DYSMORPHOLOGY, 2000, 9 (04) :295-296